E Fund Management Co., Ltd. Morphic Holding, Inc. Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$26.64 - $40.31 $12,094 - $18,300	-454 Reduced 4.17%	10,434 $367,000
Q4 2023 Feb 06, 2024	BUY	$19.95 - $31.0 $217,215 - $337,528	10,888 New	10,888 $314,000
Q2 2023 Aug 11, 2023	BUY	$34.33 - $62.11 $240,001 - $434,211	6,991 New	6,991 $401,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $182,910 - $398,530	9,266 New	9,266 $201,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.